Kenrick Does

Kenrick Does has extensive work experience in regulatory affairs, specifically in the area of CMC (Chemistry, Manufacturing, and Controls). Kenrick has worked in various roles and companies, including:

- Currently, they are the Executive Director Global Regulatory Affairs CMC at Pharvaris, where they are responsible for developing regulatory CMC strategies and managing preparation of regulatory submissions.

- From 2017 to 2022, they worked as the Global Head Regulatory Affairs CMC at Fresenius Kabi, managing a team involved in regulatory CMC activities for Biosimilar products.

- From 2013 to 2017, they served as the Director Regulatory Affairs at Merck Seronno, where they were the CMC Lead for several biotech development products and responsible for developing strategies and managing preparation of regulatory submissions.

- From 2010 to 2013, they worked as the Senior Manager Regulatory Affairs CMC at UCB Pharma, where they were the Regional Lead for UCB's key centralized biotech product and responsible for major CMC variations and new applications in different markets.

- From 2005 to 2010, they were the Senior Manager Regulatory Affairs CMC at Biogen Idec, working in the Netherlands and Denmark. Kenrick focused on Biogen's centralised biotech products and early and late-stage development products, responsible for preparation of IMPDs and lifecycle management for various other products.

- From 2001 to 2005, they worked as a regulatory affairs specialist at Chiron Corporation, managing regulatory submissions and acting as the primary interface for CMC matters.

- In 1997, they started their career as a QA Specialist at Merck Sharp & Dohme.

Kenrick Does holds a Master of Science (MSc) degree in Pharmacochemie, which they obtained from Vrije Universiteit Amsterdam (VU Amsterdam) from 1994 to 1997. Prior to that, they pursued a Bachelor of Science (BSc) degree in Organic Chemistry from HBO University, where they studied from 1989 to 1994.